This exhibition focuses on the whole industrial chain of biotechnology, life sciences, high-end medical devices, biomedicine, chronic disease prevention and treatment, and gives a summary of the latest pattern of biomedicine.

The listing application for ALK inhibitor Ensatinib Hydrochloride submitted by Betta Pharmaceuticals was approved by the National Medical Products Administration.

The China - asean BBS to traditional medicine "traditional medicine development and human destiny community building" as the theme, focus on traditional medicine and COVID - 19 epidemic prevention and control and traditional medical and health industry, carries on the discussion and communication, e......

Phase III clinical trial of COVID-19 vaccine in China has officially started, with no significant side effects among the volunteers

The first-generation FLT-3 inhibitors that have been marketed are all multi-target inhibitors and have some inevitable side effects, such as diarrhea, anorexia, fatigue, nausea, rash, acne, joint pain, etc.; therefore, more For high-efficiency FLT-3 inhibitors have been developed and approved for ma......

After the expiration of global blockbuster drug patents, the rapid development of generic drugs has brought an explosive growth in the demand for API and intermediates, which can be dated back to omeprazole and other products from the 1990s, bringing huge profits to Indian pharmaceutical companies a......